Loading clinical trials...
Loading clinical trials...
ATLAS-PEDS: An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
Conditions
Interventions
Fitusiran
Locations
16
United States
Children's Hospital Los Angeles Site Number : 8400002
Los Angeles, California, United States
Hackensack University Medical Center- Site Number : 8400008
Hackensack, New Jersey, United States
University Hospitals of Cleveland- Site Number : 8400007
Cleveland, Ohio, United States
Penn State Milton S. Hershey Medical Center- Site Number : 8400006
Hershey, Pennsylvania, United States
Investigational Site Number : 1240001
Hamilton, Ontario, Canada
Investigational Site Number : 1240002
Ottawa, Ontario, Canada
Start Date
January 28, 2020
Primary Completion Date
August 15, 2026
Completion Date
December 15, 2026
Last Updated
August 8, 2025
NCT06379789
NCT07226206
NCT05987449
NCT06008938
NCT04645199
NCT07080905
Lead Sponsor
Genzyme, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions